The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(100)

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones

In this episode of “The Top Line,” recorded on site at Fierce Biotech Week in Boston, Fierce’s Ayla Ellison sits down with Christelle Huguet, Ph.D., executive vice president and head of R&D at Ipsen, ...

12 Kesä 15min

Why MRD is becoming central to oncology drug development (Sponsored)

Why MRD is becoming central to oncology drug development (Sponsored)

In this sponsored episode of The Top Line, experts from Myriad Genetics join host Stephanie Butler to examine how tumor-informed molecular residual disease, or MRD, testing is beginning to redefine wh...

10 Kesä 18min

Behind the headlines of ASCO 2026

Behind the headlines of ASCO 2026

Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s annual meeting for a weekend of buzzy data drops, practice-changing posters and ins...

5 Kesä 29min

Mesutoclax points to possible shift in high-risk MDS and AML (Sponsored)

Mesutoclax points to possible shift in high-risk MDS and AML (Sponsored)

High‑risk MDS and AML continue to challenge clinicians, with limited durable responses and few options for older or treatment‑refractory patients. In this sponsored episode of The Top Line, host Steph...

3 Kesä 21min

Boston, China and the future of biotech

Boston, China and the future of biotech

Boston remains biotech's most influential hub, but the questions facing the region are increasingly global. Recorded live at Fierce Biotech Week in Boston, this panel discussion brings together Uli St...

29 Touko 35min

Why direct-to-patient is the future of pharma access (Sponsored)

Why direct-to-patient is the future of pharma access (Sponsored)

Direct-to-patient models are no longer an experiment - they're becoming a critical part of the modern prescription journey. In this sponsored episode of The Top Line, host Kelly Hogan talks with Jerem...

28 Touko 9min

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

Recorded last week at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with Kristen Fortney, Ph.D., co-founder and CEO of BioAge Labs. In a conversation with Ayla ...

22 Touko 12min

Designing an agentic, future‑ready tech roadmap for emerging pharma (Sponsored)

Designing an agentic, future‑ready tech roadmap for emerging pharma (Sponsored)

Emerging pharma organizations face unique technology challenges as they prepare for launch. Expectations for AI-enabled decision-making continue to rise, even as teams remain small and operate in high...

18 Touko 28min

Suosittua kategoriassa Politiikka ja uutiset

uutiscast
vallattomat
aikalisa
politiikan-puskaradio
rss-viihde-media
rss-ootsa-kuullut-tasta
ootsa-kuullut-tasta-2
rss-vaalirankkurit-podcast
rss-voi-venaja
the-ulkopolitist
tervo-halme
otetaan-yhdet
rss-asiastudio
rss-kaikki-uusiksi
rss-vihrea-tuuma
rss-toisten-taskuilla
rss-ulkopoditiikkaa
rss-raha-talous-ja-politiikka
rss-girls-finish-f1rst
rss-podme-livebox